Hepatitis: all 3,372 studies
Page 15 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- A Study of the Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian FederationCompletedNCT04189627
- Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B PatientsStatus unknownNCT04189276Phase 2
- Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & ChildrenCompletedNCT04188223Phase 1
- Metformin as Add-on to the Standard Therapy in Patients With Chronic Hepatitis BCompletedNCT04182321Not applicable
- A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis BStatus unknownNCT04180150Phase 2
- Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 VillagesCompletedNCT04177043Phase 4
- Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis DeltaStatus unknownNCT04170452
- Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B PatientsCompletedNCT04168333Phase 1
- Hepatitis B Vaccine in SeniorsCompletedNCT04162223Early Phase 1
- Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated CirrhosisStatus unknownNCT04160897
- Future Destinations: Journeys Towards CitizenshipCompletedNCT04159545
- An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis bStatus unknownNCT04157699Phase 2
- An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) TherapyStatus unknownNCT04157257Phase 2
- Retrieval of Hepatitis C Patients Lost to Follow-upStatus unknownNCT04153708Not applicable
- Alcoholic Hepatitis in Latin-America: A Prospective and Multicentric Study (AH-LATIN).Status unknownNCT04142723
- Evaluation Study of HCV RDTs in Fresh SamplesCompletedNCT04139941
- Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Region in Burkina FasoStatus unknownNCT04136405
- Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis BStatus unknownNCT04135235
- Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B PatientsStatus unknownNCT04133259Phase 2
- A Phase 2a Study to Evaluate the Safety and Efficacy of Cannabidiol Only as Maintenance Therapy and Steroid Sparing in Patients With Stable Autoimmune HepatitisTerminatedNCT04129489Phase 2
- Study on PK of Hydronidone in Patients and Special PopulationCompletedNCT04123769Phase 1
- Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.CompletedNCT04114890Phase 2
- Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple TherapyStatus unknownNCT04113915
- Simplified Monitoring Myanmar SM2 StudyCompletedNCT04113629Not applicable
- Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection PatientsStatus unknownNCT04111367Phase 2
- Preliminary Validation of an in Vitro Diagnosis-medical Device for Hepatitis B ScreeningCompletedNCT04109625Not applicable
- Invasive Fungal Infections in Severe Alcohol-associated HepatitisStatus unknownNCT04103840
- Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus InfectionCompletedNCT04094272
- Effect of Saturated Fat (Desi Ghee) on Gut-Liver Axis in Alcoholic HepatitisCompletedNCT04084522Not applicable
- Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD PatientsCompletedNCT04083157Phase 2/3
- Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg)CompletedNCT04075201Phase 1
- Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy InfantsStatus unknownNCT04073459Phase 2
- Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis BCompletedNCT04071379Phase 3
- Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis CStatus unknownNCT04071353
- SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis CStatus unknownNCT04070235Phase 2/3
- Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B:Status unknownNCT04070079Phase 4
- Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis BStatus unknownNCT04069858Phase 4
- Efficacy of Monotherapy vs Combination Therapy of Corticosteroids With GCSF in Severe Alcoholic Hepatitis Patients.Status unknownNCT04066179Not applicable
- Study of Tenofovir Alafenamide Fumarate Tablets (TAF) in Blocking Mother-to-child Transmission of Hepatitis B VirusStatus unknownNCT04065230
- HCV Treatment in a Low-threshold ClinicStatus unknownNCT04063839
- Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in MadridCompletedNCT04062253
- Eliminate Hepatitis C/EC Partnership Evaluation ProtocolStatus unknownNCT04061551Not applicable
- Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B VirusTerminatedNCT04059198Phase 2
- Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant StudyTerminatedNCT04057001
- Zepatier in Patients with Substance UseCompletedNCT04048850
- eGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAsCompletedNCT04047680
- Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral TherapyWithdrawnNCT04046107Phase 1/2
- Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus InfectionWithdrawnNCT04044651Phase 2/3
- Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in BrazilStatus unknownNCT04039698Not applicable
- Hepatitis D Virus Infection Among Hepatitis B Virus Surface Antigen Positive IndividualsCompletedNCT04038372
- Simplified Antiviral Treatment Strategy for Hepatitis C in UkraineCompletedNCT04038320
- Integrating Hepatitis C Screening With Dried Blood Spot Testing Into Colorectal Cancer ScreeningCompletedNCT04037046Not applicable
- Implementation and Evaluation of Care Coordination in Linkage to Care for Hepatitis C Following Release From New York City JailsCompletedNCT04036760
- The Clinical Cure Project of Chronic Hepatitis B in ChinaActive, not recruitingNCT04035837Phase 4
- Evaluation Study of RDTs Detecting Antibodies Against HCVCompletedNCT04033887
- Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT CellsStatus unknownNCT04032392Phase 1
- Correlation Between Virus and Biochemical Characteristics and Liver Histological Damage in Untreated Chronic HBV InfectionCompletedNCT04032275
- Cohort Study of Clinical Outcomes in Chronic HBV Infection Patients With Low HBsAg Under Unplanned InterventionStatus unknownNCT04030039
- Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization ScheduleCompletedNCT04029454Not applicable
- Re-engaging Patients With Hepatitis C Into CareStatus unknownNCT04029246Not applicable
- Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis BCompletedNCT04028856
- Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC InhibitorTerminatedNCT04023721Phase 2
- Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) InfectionCompletedNCT04019717Phase 2
- Transplantation Using Hepatitis C Positive Donors, A Safety TrialStatus unknownNCT04017338Phase 3
- SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization TherapyCompletedNCT04015245Phase 4
- A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)CompletedNCT04008004Phase 1
- Self-testing for HCV Re-infection in MSMStatus unknownNCT04004299Not applicable
- The DETECT HCV Screening TrialCompletedNCT04003454Not applicable
- Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection PatientsStatus unknownNCT04001608Phase 3
- KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis CCompletedNCT03995485Phase 3
- Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong KongActive, not recruitingNCT03993925
- Sexual and Reproductive Health (Including PrEP and HBV) for Female Sex Workers in Côte d'IvoireStatus unknownNCT03985085Not applicable
- Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject DrugsTerminatedNCT03981211Not applicable
- Screening Hepatitis Positive Women for Congenital AnomaliesCompletedNCT03980301
- Quantitative Magnetic Resonance Imaging to Aid Clinical Decision Making in Autoimmune Hepatitis.CompletedNCT03979053
- Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child TransmissionCompletedNCT03977987
- Prediction Model Based on Computed Tomography Liver Volume for the Short-term Mortality in Hepatitis B Related Acute-on-ChronicCompletedNCT03977857
- Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PDStatus unknownNCT03973502Not applicable
- Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis PatientsStatus unknownNCT03969017Phase 2
- Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease PopulationStatus unknownNCT03962881Phase 4
- Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment PatientsStatus unknownNCT03962816Phase 4
- Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected PatientsStatus unknownNCT03962803Phase 4
- Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver FibrosisStatus unknownNCT03957629Not applicable
- Characterization of the Relationship Between the Human Mesolimbic Reward System and Immune FunctioningCompletedNCT03951870Not applicable
- Immunology of HIV and Alcoholic HepatitisWithdrawnNCT03951662
- Glecaprevir/Pibrentasvir Real-world Study in ChinaStatus unknownNCT03941821
- Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar)CompletedNCT03939013Not applicable
- Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B PatientsTerminatedNCT03932513Phase 2
- A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative MeasuresStatus unknownNCT03932396
- The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 WeeksCompletedNCT03931239Not applicable
- Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver FibrosisStatus unknownNCT03920605Not applicable
- Protectivity and Safety Following Recombinant Hepatitis B VaccineCompletedNCT03919578Phase 2/3
- Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver FibrosisStatus unknownNCT03919565Not applicable
- DUR-928 in Patients With Alcoholic HepatitisCompletedNCT03917407Phase 2
- Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral AgentsCompletedNCT03908294
- Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological MalignancyCompletedNCT03903185Phase 1/2
- Evaluation of Dried Blood Spot for HCV RNA TestingCompletedNCT03896087Not applicable
- Effect of Strategies for the Treatment of Chronic Hepatitis C in ColombiaStatus unknownNCT03895294Not applicable
- Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral AgentsStatus unknownNCT03894696
- Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular CarcinomaStatus unknownNCT03892681Not applicable